v.salgado
TL2 · Konya
Contributes reviews on supplier material. Based in Konya.
Joined 8 September 2025 · last posted 4d
82 posts, newest first. Showing up to 150.
-
What is genuinely unknown about long-term amylin agonism Replied, post #81 · Compounds › Cagrilintide & amylin analogues · 24 Jul 2026 · 2 likes Research-use-only cagrilintide is not approved for human use and the published evidence base is a clinical-trial evidence base. Those two facts sit uncomfortably…
-
Does a peptide degrade silently, with no visual change? Replied, post #76 · Practice › Storage & stability · 22 Jul 2026 · 21 likes Answering the question post #74 raises rather than the one it answers. The practical version of peptide is three sentences long. The rigorous version is three pages and…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #98 · Start Here › Welcome · 21 Jul 2026 · 0 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
-
Seven-day rolling means and why weekly readings mislead Replied, post #28 · Outcomes › Progress reports · 14 Jul 2026 · 16 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #56 · Nutrition & Training › Protein & intake · 12 Jul 2026 · 1 like Post #52 put the caveat in the right place and I want to underline it. Liquid sources are tolerated better than solid ones by many people here, and that is a practical…
-
CJC-1295 with and without DAC: what the modification does Replied, post #109 · Compounds › Secretagogues & GH axis · 11 Jul 2026 · 0 likes Where the CJC-1295 discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #73 · Start Here › Welcome · 10 Jul 2026 · 8 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
What to include when your question involves a chromatogram — one year on Replied, post #60 · Start Here › How to Ask · 2 Jul 2026 · 29 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. Caveat: everything above assumes the…
-
Aggregate verification data across the directory, with caveats Replied, post #6 · Sourcing › Independent verification · 20 Jun 2026 · 0 likes Post #4 put the caveat in the right place and I want to underline it. Repeat determination on the same product line months apart is the measurement that speaks to…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #45 · Evidence › Journal club · 19 Jun 2026 · 5 likes Two sentences on SURMOUNT-OSA and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #9 · marked as the solution · Access › Shortages · 4 Jun 2026 · 7 likes Building on post #8 rather than restating it. Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #29 · Practice › Dosing & titration · 18 May 2026 · 7 likes Everything in post #25 holds. The case it does not cover is the one I have. Holding at a dose that is working is a legitimate position and it is not what the trial…
-
Official shortage notices and what they authorise Replied, post #53 · Access › Shortages · 16 May 2026 · 10 likes Saving this. It is the version I will quote when the question comes round again.
-
Cold solution and stinging: the simplest fix Replied, post #25 · Practice › Administration · 14 May 2026 · 12 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #6 · Evidence › Trials · 6 May 2026 · 32 likes Where I part company with post #3, and it is a narrow parting. A treatment-policy estimand asks what happens to people assigned to a strategy, including those who…
-
About the COA interpretation category Replied, post #10 · Analytics › COA interpretation · 1 May 2026 · 9 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Reading a home test result without over-claiming Replied, post #25 · Analytics › Home & field testing · 28 Apr 2026 · 7 likes Where I part company with post #23, and it is a narrow parting. Quantitation at home is the part that does not survive scrutiny. Precision adequate to distinguish 96…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #89 · Practice › Reconstitution · 23 Apr 2026 · 0 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Journal club: is percentage weight change the right endpoint? Replied, post #75 · Evidence › Journal club · 17 Apr 2026 · 0 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #76 · Compounds › Tirzepatide · 9 Apr 2026 · 0 likes Coming back to post #75, because the follow-up matters more than the original answer. Since 2.5 mg starting dose keeps coming up, it should probably be a maintained…
-
Semaglutide formulation: what is in the licensed product besides the peptide Started this topic · Compounds › Semaglutide · 5 Apr 2026 · 4 likes Semaglutide formulation: what is in the licensed product besides the peptide — setting out what I have, and where I think it stops being reliable. I have spent a…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #95 · Analytics › Mass spectrometry · 4 Apr 2026 · 24 likes Worth separating two things that post #91 runs together. On Adducts, the part that usually goes wrong is that the question is asked as though it has one answer. It has…
-
GLP-1 receptor distribution: central and peripheral Replied, post #24 · Pharmacology › Receptor biology · 31 Mar 2026 · 13 likes In vitro potency and clinical potency are related by a long chain of assumptions. A compound more potent at the receptor is not necessarily more effective at a…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #45 · Outcomes › Body composition · 21 Mar 2026 · 6 likes Lean mass preservation sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Solubility limits and what a cloudy solution is telling you Replied, post #5 · Pharmacology › Formulation chemistry · 14 Mar 2026 · 27 likes No disagreement from me. Posting only so the question does not look ignored.
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #42 · Lounge › Introductions · 12 Mar 2026 · 0 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #64 · Outcomes › Body composition · 7 Mar 2026 · 1 like The arithmetic in post #63 is right; the assumption feeding it is the part to check. For anyone finding this later: the short answer on Circumference measurements is…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #5 · Pharmacology › Formulation chemistry · 26 Feb 2026 · 1 like I think the Solubility limits question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #80 · Meta › Site feedback · 23 Feb 2026 · 11 likes I had written a reply contradicting post #78 and deleted it. Here is what survived. Navigation problems: if you cannot find something you expected to exist, or the path…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #103 · Practice › Dosing & titration · 20 Feb 2026 · 0 likes Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #63 · Analytics › Mass spectrometry · 14 Feb 2026 · 17 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #14 · Practice › Interactions · 5 Feb 2026 · 16 likes Reframing anaesthesia and elective surgery slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen",…
-
Trifluoroacetate content and its consequences Replied, post #52 · Analytics › Impurities & related substances · 31 Jan 2026 · 0 likes No notes. Posting so the count is not one.
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #38 · Documentation › Wiki requests · 14 Jan 2026 · 32 likes Objections to a request belong in the open, and a request that survives an objection is a stronger page for it. This has been discussed before and I could not find the…
-
[2026 update] Evidence quality in the secretagogue literature: an honest assessment Replied, post #7 · Compounds › Secretagogues & GH axis · 5 Jan 2026 · 17 likes Picking up post #4: that is the part I would want checked first. My understanding of Evidence quality is a few years old and may have been superseded. If it has been, I…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #31 · Practice › Dosing & titration · 22 Dec 2025 · 5 likes The four-week step is a trial convention, not a pharmacological constant. It is roughly four half-lives for a week-long half-life, which is the interval at which you…
-
Second pass at: Temperature logging at home: what is worth the effort Started this topic · Practice › Storage & stability · 14 Dec 2025 · 12 likes Posting this under the heading it deserves: Second pass at: Temperature logging at home: what is worth the effort Everything below is what sits behind that. Posting a…
-
[2026 update] What steady state means for the decision to escalate Replied, post #117 · Practice › Dosing & titration · 17 Nov 2025 · 7 likes I had written a reply contradicting post #116 and deleted it. Here is what survived. Concentration and dose get conflated constantly in this subcategory. Changing how…
-
Lurking for two months before posting: was that the right call? Replied, post #4 · Start Here › Welcome · 16 Nov 2025 · 1 like Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #21 · Meta › Announcements · 10 Nov 2025 · 21 likes Confirming post #19 from a second method, which matters more than confirming it from a second person. On Scheduled maintenance the community has more anecdote than the…
-
Availability by country, dated, with primary sources Replied, post #34 · Access › International · 26 Oct 2025 · 19 likes Post #33 is the version of this I will quote in future. One addition. The strongest argument against my own position on availability, stated as well as I can state it,…
-
New subcategory: rationale and scope Replied, post #52 · Meta › Announcements · 18 Oct 2025 · 24 likes Building on post #50 rather than restating it. The rare case here is the one that costs somebody a week, though, and the common case costs everyone ten seconds. I think…
-
Titles that describe the question, not the situation Replied, post #101 · Start Here › How to Ask · 20 Sep 2025 · 0 likes Adding the measurement that post #98 says would settle it. I keep a log for titles specifically because my memory of it turned out to be systematically wrong in one…
-
Reading SURMOUNT-1 without the press release Replied, post #11 · Compounds › Tirzepatide · 18 Sep 2025 · 6 likes Reading SURMOUNT-1 without the press is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #84 · Compounds › Secretagogues & GH axis · 21 Aug 2025 · 0 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #7 · Documentation › Doc review · 18 Aug 2025 · 2 likes Post #3 put the caveat in the right place and I want to underline it. The limitations section is the part most often thin at review and most often load-bearing…
-
A request that was declined, and the reasoning — a second dataset Replied, post #59 · Documentation › Wiki requests · 12 Aug 2025 · 0 likes A request is more likely to succeed with a proposed outline attached. "Somebody should write about X" rarely moves; a structure and two sections does. Noting that I…
-
Counter-ion content and its effect on measured mass Replied, post #107 · Analytics › Mass spectrometry · 30 Jul 2025 · 6 likes This settles it for me, at least until somebody posts a reason it should not.
-
An appeal that failed, and what I would do differently Replied, post #8 · Access › Insurance & coverage · 21 Jul 2025 · 13 likes Post #5 is the version of this I will quote in future. One addition. Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it…
-
[2026 update] Splitting an overlong document into two Replied, post #15 · Documentation › Wiki requests · 8 Jul 2025 · 4 likes Where an existing document nearly covers it, extending that one is usually better than starting a new one. Two overlapping pages drift apart. That is what the…
-
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #17 · Practice › Administration · 29 Jun 2025 · 3 likes A request rather than an answer: could whoever has the primary source for Completing a dose post it? I have seen the claim three times this month and each version had…
-
Sequence verification for an obscure compound: how it is done Replied, post #73 · Compounds › Other compounds · 25 Jun 2025 · 0 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
Revisiting: What to include when your question involves arithmetic Replied, post #6 · Start Here › How to Ask · 24 Jun 2025 · 20 likes This follows post #4 rather than contradicting it. Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #61 · Devices › Pens & autoinjectors · 8 Jun 2025 · 12 likes Worth separating two things that post #59 runs together. Reading the dose window rather than the dial position is worth the habit. On several devices the two do not…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #116 · Devices › Cold chain · 4 Jun 2025 · 0 likes Adding the measurement that post #115 says would settle it. A note on how Domestic fridge temperature mapping gets discussed rather than on Domestic fridge temperature…
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #17 · Clinical › Bloodwork · 9 May 2025 · 0 likes Useful. I have added it to my own notes with the date on it.
-
Lean mass preservation: what the evidence supports Replied, post #8 · Outcomes › Body composition · 8 May 2025 · 0 likes Percentage body fat is a ratio, so it changes when either component changes. A rising percentage during weight loss is arithmetic before it is physiology. Noting that…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #93 · Compounds › Semaglutide · 27 Apr 2025 · 0 likes Worth separating two things that post #91 runs together. On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at…
-
Criticising the method without criticising the authors Replied, post #53 · Evidence › Study critique · 5 Apr 2025 · 22 likes Criticising the method without criticising has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #84 · Documentation › Doc review · 1 Apr 2025 · 0 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #54 · Compounds › Secretagogues & GH axis · 28 Mar 2025 · 0 likes Pulsatile secretion is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
-
Albumin binding and how it produces a long half-life Replied, post #16 · Pharmacology › Pharmacokinetics · 20 Mar 2025 · 3 likes I had written a reply contradicting post #13 and deleted it. Here is what survived. Where two sources give different half-lives, check the study design before deciding…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #69 · Sourcing › Regulatory · 2 Mar 2025 · 1 like If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category. I would…
-
Protein density versus volume when you cannot eat much Replied, post #93 · Nutrition & Training › Protein & intake · 8 Feb 2025 · 3 likes Temperature and texture change what is tolerable for a lot of people during the first weeks, and that is worth experimenting with before concluding nothing works.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #21 · Access › International · 31 Jan 2025 · 9 likes Worth stating the null on Cross-border purchase within before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not…
-
Follow-up: Individual participant data versus aggregate data Replied, post #69 · Evidence › Meta-analyses · 10 Jan 2025 · 30 likes Practical experience of Individual participant data versus aggregate, offered as one case with the conditions stated, not as a general finding. Conditions first,…
-
What we do not know about retatrutide, listed explicitly Replied, post #49 · Compounds › Retatrutide · 9 Jan 2025 · 1 like Thank you — that answers what I came here to find out.
-
Second pass at: Albumin binding and how it produces a long half-life Replied, post #9 · Pharmacology › Pharmacokinetics · 7 Jan 2025 · 4 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #150 · Compounds › Oral incretins · 29 Dec 2024 · 0 likes PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled a diabetes population at high cardiovascular risk. Quoting it outside that population…
-
Body image changing more slowly than the body Replied, post #98 · Wellbeing › Mental health · 22 Dec 2024 · 32 likes The claim about body image upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
-
Body image changing more slowly than the body Replied, post #73 · Wellbeing › Mental health · 19 Dec 2024 · 20 likes Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be psychologically complex. Some of that is positive;…
-
[2026 update] New subcategory: rationale and scope Replied, post #55 · Meta › Announcements · 10 Dec 2024 · 0 likes Whatever the answer on New subcategory turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
-
EMA product information as a primary source — does this still hold? Replied, post #110 · Regional › European Union · 18 Nov 2024 · 10 likes Where the EMA product information reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
EMA product information as a primary source — does this still hold? Replied, post #98 · Regional › European Union · 17 Nov 2024 · 0 likes Answering the EMA product information question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how…
-
When to suspect the method rather than the sample Replied, post #30 · Analytics › Method validation · 30 Oct 2024 · 11 likes A method that reports the same number for every lot is worth a second look. Real processes vary, and a total absence of variation is a statement about the measurement…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #73 · Analytics › COA interpretation · 3 Oct 2024 · 0 likes The most useful thing anyone has posted about field-by-field walk through a certificate in this category was a table of what had been measured and by whom. That is what…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #6 · Start Here › Welcome · 12 Sep 2024 · 0 likes Worth knowing early: the archive is not retrospectively corrected. A topic from two years ago was accurate when written and may not be now. Every post carries its date…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #34 · Evidence › Preprints · 5 Sep 2024 · 27 likes Where a preprint's numbers are the basis of a claim being repeated here, someone should check whether the published version exists yet. That check is nearly always…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #49 · Nutrition & Training › Hydration & electrolytes · 20 Aug 2024 · 0 likes Everything in post #47 holds. The case it does not cover is the one I have. Before the thread moves on from Sodium — what is the sample size behind the claim? I am not…
-
Naming conventions for research peptides and the confusion they cause — one year on Replied, post #3 · Compounds › Other compounds · 17 Jul 2024 · 32 likes Anything in this subcategory with a published trial behind it should be discussed separately from anything without one. Mixing them produces a discussion where the…
-
Journal club: FLOW and the renal composite, component by component Replied, post #59 · Evidence › Journal club · 14 Jul 2024 · 28 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. The…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #24 · Practice › Dosing & titration · 18 Jun 2024 · 1 like Everything in post #22 holds. The case it does not cover is the one I have. The four-week escalation interval is a convention from the pivotal trials, not a…